摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-N-methyl-N-(1-methyl-1 H-indol-2-ylmethyl)-3-(3-methyl-2-oxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidin-6-yl)acrylamide | 335028-19-8

中文名称
——
中文别名
——
英文名称
(E)-N-methyl-N-(1-methyl-1 H-indol-2-ylmethyl)-3-(3-methyl-2-oxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidin-6-yl)acrylamide
英文别名
(E)-N-methyl-N-[(1-methylindol-2-yl)methyl]-3-(3-methyl-2-oxo-1,4-dihydropyrido[2,3-d]pyrimidin-6-yl)prop-2-enamide
(E)-N-methyl-N-(1-methyl-1 H-indol-2-ylmethyl)-3-(3-methyl-2-oxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidin-6-yl)acrylamide化学式
CAS
335028-19-8
化学式
C22H23N5O2
mdl
——
分子量
389.457
InChiKey
WNBHKHHXEHQTLZ-CMDGGOBGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    29
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    70.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] ANTIBIOTICS EFFECTIVE FOR GRAM-NEGATIVE PATHOGENS<br/>[FR] ANTIBIOTIQUES EFFICACES CONTRE LES PATHOGÈNES GRAM-NÉGATIFS
    申请人:UNIV ILLINOIS
    公开号:WO2019177975A1
    公开(公告)日:2019-09-19
    Disclosed herein are antibacterial compounds that accumulate in Gram-negative bacteria, methods of preparing the compounds, and methods of using the compounds to inhibit or kill microbes, and methods of treating microbial infections, such as Gram-negative bacterial infections. Compounds selected for conversion to potential Gram-negative antibacterial compounds were identified based on compounds having low globularity and low flexibility. Amine substituents were then strategically added to the selected compounds to provide compounds having antibacterial activity against Gram-negative bacteria.
    本文披露了在革兰氏阴性细菌中积累的抗菌化合物,制备这些化合物的方法,以及利用这些化合物抑制或杀灭微生物,以及治疗微生物感染的方法,如革兰氏阴性细菌感染。选择用于转化为潜在革兰氏阴性抗菌化合物的化合物是基于具有低球形度和低柔性的化合物。然后在所选的化合物中策略性地添加氨基取代基,以提供对革兰氏阴性细菌具有抗菌活性的化合物。
  • [EN] FAB I INHIBITORS<br/>[FR] INHIBITEURS DE FAB I
    申请人:SMITHKLINE BEECHAM CORP
    公开号:WO2001027103A1
    公开(公告)日:2001-04-19
    Compounds of formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment of bacterial infections. In said formula, (A) is (a), (b), (c), (d), (e), (f), (g), (h), (i), (j), (k), (l), (m), (n), (o) or (p); (I) wherein R1 is H or C¿1-4?alkyl; R?2¿ is H, C¿1-4?alkyl or C3-6cycloalkyl; R?3¿ is (q), (r), (s), (t), (u), (v) or (w); R4 is H or C¿1-4?alkyl; (x) indicates that one of the two designated bonds is a double bond and the other is a single bond; R?5¿ is CH¿2? when the bond to which it is attached is a double bond; or R?5¿ is H or C¿1-4?alkyl when the bond to which it is attached is a single bond; R?6¿ is H or C¿1-4?alkyl; R?7¿ is H, C¿1-6?alkyl or -C0-6alkyl-Ar; Y is H, C1-4alkyl, N(R')2, NHC(O)R', NHCH2C(O)R' or NHC(O)CH=CHR'; each X independently is H, C1-4alkyl, CH2OH, OR', SR', CN, N(R')2, CH2N(R')2, NO2, CF3, CO2R', CON(R')2, COR', NR'C(O)R', F, Cl, Br, I or -S(O)rCF3; W is S or O, Q is H or C1-4alkyl; M is CH2 or O; L is CH2 or C(O); E is O or NR'; each R' independently is H, C1-6alkyl or -C0-6alkyl-Ar; and r is 0, 1 or 2; or a pharmaceutically acceptable salt thereof.
    公开了式(I)的化合物,它们是Fab I抑制剂,可用于治疗细菌感染。在所述式中,(A)是(a),(b),(c),(d),(e),(f),(g),(h),(i),(j),(k),(l),(m),(n),(o)或(p);(I),其中R1为H或C1-4烷基; R?2¿为H,C1-4烷基或C3-6环烷基; R?3¿为(q),(r),(s),(t),(u),(v)或(w); R4为H或C1-4烷基;(x)表示两个指定键中的一个是双键,另一个是单键;当其所连接的键是双键时,R?5¿为CH2;当其所连接的键是单键时,R?5¿为H或C1-4烷基; R?6¿为H或C1-4烷基; R?7¿为H,C1-6烷基或-C0-6烷基-Ar; Y为H,C1-4烷基,N(R')2,NHC(O)R',NHCH2C(O)R'或NHC(O)CH = CHR';每个X独立地为H,C1-4烷基,CH2OH,OR',SR',CN,N(R')2,CH2N(R')2,NO2,CF3,CO2R',CON(R')2,COR',NR'C(O)R',F,Cl,Br,I或-S(O)rCF3; W为S或O,Q为H或C1-4烷基; M为CH2或O; L为CH2或C(O); E为O或NR';每个R'独立地为H,C1-6烷基或-C0-6烷基-Ar; r为0、1或2;或其药学上可接受的盐。
  • FAB I inhibitors
    申请人:Miller H. William
    公开号:US20050250810A1
    公开(公告)日:2005-11-10
    Compounds of the formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment of bacterial infections.
    公式(I)的化合物被揭示为Fab I抑制剂,可用于治疗细菌感染。
  • Fab I Inhibitors
    申请人:Burgess Walter J.
    公开号:US20090221699A1
    公开(公告)日:2009-09-03
    Compounds are disclosed which are Fab I inhibitors and are useful in the treatment bacterial infections.
    本发明揭示了一种Fab I抑制剂,可用于治疗细菌感染。
  • Compositions Comprising Multiple Bioactive Agents, and Methods of Using the Same
    申请人:BERMAN JUDD M.
    公开号:US20120010127A1
    公开(公告)日:2012-01-12
    In part, the present invention is directed to compositions comprising a FabI inhibitor and at least one other bioactive agent. In another part, the present invention is directed to antibacterial compositions comprising a compound of formulas I-III and at least one other antibacterial agent.
    本发明的一部分涉及包含FabI抑制剂和至少一种其他生物活性剂的组合物。另一部分涉及包含I-III式化合物和至少一种其他抗菌剂的抗菌组合物。
查看更多

同类化合物

阿昔替酯 螺喹唑啉 苯并[g][1,2,3]三唑并[4',5':5,6]吡啶并[2,1-b]喹唑啉-13(2H)-酮 脱氢利培酮 盐酸曲林菌素 甲硫利马唑 甲基8-乙基-2-甲氧基-5-氧代-5,8-二氢吡啶并[2,3-d]嘧啶-6-羧酸酯 甲基8-乙基-2-(甲硫基)-5-氧代-5,6,7,8-四氢吡啶并[2,3-d]嘧啶-6-羧酸酯 甲基2-乙氧基-8-乙基-5-氧代-吡啶并[6,5-d]嘧啶-6-羧酸酯 溴他替尼 泮托拉唑杂质DF 氨甲酸,[(2R,3E)-2-羟基-3-戊烯基]-,1,1-二甲基乙基酯(9CI) 柱孢藻毒素 曲美替尼 曲美替尼 曲喹辛 帕潘立酮棕榈酸酯 帕潘立酮杂质7 帕潘立酮杂质 帕潘立酮杂质 帕潘立酮 帕泊昔布杂质117 帕利哌酮十四酸酯 帕利哌酮N-氧化物 布喹特林 巴马斯汀 奥卡哌酮 多夸司特 吡曲克辛 吡嘧司特钾 吡嘧司特 吡啶并[4,3-d]嘧啶-4(1H)-酮,4,5,6,7-四氢-6-甲基-2-苯基- 吡啶并[4,3-D]嘧啶-2,4(1H,3H)-二酮 吡啶并[3,4-D]嘧啶-2,4(1H,3H)-二酮 吡啶并[3,2-d]嘧啶-4(3H)-酮,3-甲基-2-(甲基氨基)- 吡啶并[3,2-d]嘧啶-4(3H)-酮 吡啶并[3,2-d]嘧啶-4(1H)-酮,2,3-二氢-3-(2-羟基苯基)-2-硫代- 吡啶并[3,2-d]嘧啶-2,4(1H,3H)-二酮 吡啶并[2,3-d]嘧啶-7(8h)-酮,2,6-二溴-8-环戊基-5-甲基- 吡啶并[2,3-d]嘧啶-7(8H)-酮 吡啶并[2,3-d]嘧啶-7(1H)-酮,4-氨基-5,6-二氢-5-甲基- 吡啶并[2,3-d]嘧啶-6-羧酸,1-(2,4-二甲基苯基)-1,4-二氢-2,7-二甲基-4-羰基-,酰肼 吡啶并[2,3-d]嘧啶-4(3H)-酮,5,7-二甲基-2-(甲硫基)-3-苯基- 吡啶并[2,3-d]嘧啶-4(3H)-酮 吡啶并[2,3-d]嘧啶-4(1H)-酮,2,3-二氢-1-(4-甲基苯基)-2-硫代- 吡啶并[2,3-d]嘧啶-2-胺 吡啶并[2,3-d]嘧啶 吡啶并[2,3-D]嘧啶-4-胺 吡啶并[2,3-D]嘧啶-2,4,7(1H,3H,8H)-三酮 吡啶并[2,3-D]嘧啶-2,4(1H,3H)-二酮